Publications, press articles, rankings, awards
12
01, 2024
Recently, the annual IP5 Statistics Report of the world’s five largest IP offices (IP5) was issued.
26
12, 2023
Lavoix presents a review of pharmaceutical trademark and design decisions handed down by French and European Union courts.
19
12, 2023
The EPO has announced that the notice from the EPO informing about the entry into the European phase before the EPO is discontinued.
12
12, 2023
Created more than 10 years ago to gain a better understanding of developments in intellectual property, the IP Barometer also enables us to develop our services to better meet our clients’ expectations in terms of protecting and enhancing the value of their intangible assets.
23
11, 2023
The Enlarged Board of Appeal issued a decision on the consolidated referrals G 1/22 and G 2/22, ruling that the EPO is competent to assess entitlement to priority and that the “PCT joint applicants” approach is valid.
13
11, 2023
26
10, 2023
A new fiction for notification and time limit calculation will enter into force on November 1st, 2023.
7
09, 2023
Often commented on, the FREE v. FREE SBE decision (Paris Court of Appeal – Pôle 05 ch. 02, January 14, 2022 / n° 20/05019, S. A.S. FREE/S. A.S. FREE SBE) raises the question of the starting point of the period of limitation in consequence of acquiescence.
24
08, 2023
The Paris Court of Appeal recognizes the validity of a clause transferring copyright of an assignment clause in an employment contract.
11
07, 2023